肺纤维化
化学
肽
纳米纤维
肺
癌症研究
特发性肺纤维化
氧化应激
药理学
吸入
细胞凋亡
纤维化
肺损伤
腹腔注射
药物输送
炎症
活性氧
转录组
细胞
细胞生物学
作者
Hongxia Huang,Zhengzhuang Chen,Xiaojun Xiao,Ye Wu,Lixin Yin,Bingyuan Liu,Yi Ling,Feiqing Ding,Sheng Hong,Hui Cai
标识
DOI:10.1021/acs.jmedchem.6c01878
摘要
Pulmonary fibrosis (PF) is a life-threatening interstitial lung disease, which progressively impairs pulmonary function, with limited therapeutic options available. In this study, we designed CQ7, a self-assembling peptide that integrates a therapeutic peptide with a self-assembly motif. CQ7 monomers spontaneously form supramolecular nanofibers under physiological conditions, both extracellularly and intracellularly. This nanofiber structure promotes efficient lung retention and targeted pulmonary delivery, leading to enhanced anti-fibrotic efficacy. We evaluated the anti-fibrotic and anti-inflammatory effects of CQ7 in a murine PF model via both intraperitoneal and inhalation administrations. Transcriptomic sequencing and experimental validation further revealed that CQ7 may act through the regulation of mitochondrial function, reducing cellular oxidative stress and thereby regulating the apoptosis process. Collectively, this work demonstrates a novel peptide-based strategy with significant potential for improving PF outcomes and clinical translation.
科研通智能强力驱动
Strongly Powered by AbleSci AI